{"id":4084,"date":"2021-09-30T10:43:35","date_gmt":"2021-09-30T10:43:35","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=4084"},"modified":"2022-03-25T10:45:40","modified_gmt":"2022-03-25T10:45:40","slug":"nouvelle-collaboration-avec-lequipe-du-dr-david-durantel","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/nouvelle-collaboration-avec-lequipe-du-dr-david-durantel\/","title":{"rendered":"Nouvelle collaboration avec l&#8217;\u00e9quipe du Dr David Durantel"},"content":{"rendered":"<p>Suite aux donn\u00e9es positives de preuve de concept de l&#8217;\u00e9tude 203 obtenues avec Vonafexor en association avec l&#8217;interf\u00e9ron p\u00e9gyl\u00e9 (peg-IFN) chez des patients vir\u00e9miques atteints d&#8217;h\u00e9patite B chronique (CHB), une nouvelle collaboration a \u00e9t\u00e9 initi\u00e9e avec l&#8217;\u00e9quipe de David Durantel au Centre International de Recherche en Infectiologie (CIRI \u2013 INSERM U1111, <a href=\"https:\/\/ciri.ens-lyon.fr\/teams\/HepVir\" target=\u201dblank\u201d>https:\/\/ciri.ens-lyon.fr\/teams\/HepVir<\/a>).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Suite aux donn\u00e9es positives de preuve de concept de l&#8217;\u00e9tude 203 obtenues avec Vonafexor en association avec l&#8217;interf\u00e9ron p\u00e9gyl\u00e9 (peg-IFN) chez des patients vir\u00e9miques atteints d&#8217;h\u00e9patite B chronique (CHB), une nouvelle collaboration a \u00e9t\u00e9 initi\u00e9e avec l&#8217;\u00e9quipe de David Durantel au Centre International de Recherche en Infectiologie (CIRI \u2013 INSERM U1111, <a href=\"https:\/\/ciri.ens-lyon.fr\/teams\/HepVir\" target=\u201dblank\u201d>https:\/\/ciri.ens-lyon.fr\/teams\/HepVir<\/a>).<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/nouvelle-collaboration-avec-lequipe-du-dr-david-durantel\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-4084","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/latest-news-fr\/\" rel=\"category tag\">Br\u00e8ves<\/a>","rttpg_excerpt":"Suite aux donn\u00e9es positives de preuve de concept de l&#8217;\u00e9tude 203 obtenues avec Vonafexor en association avec l&#8217;interf\u00e9ron p\u00e9gyl\u00e9 (peg-IFN) chez des patients vir\u00e9miques atteints d&#8217;h\u00e9patite B chronique (CHB), une nouvelle collaboration a \u00e9t\u00e9 initi\u00e9e avec l&#8217;\u00e9quipe de David Durantel au Centre International de Recherche en Infectiologie (CIRI \u2013 INSERM U1111, https:\/\/ciri.ens-lyon.fr\/teams\/HepVir).Lire la suite&nbsp;&raquo;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4084"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4084\/revisions"}],"predecessor-version":[{"id":4086,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4084\/revisions\/4086"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}